Market Research Logo

Infectious Disease Diagnostics Market - Size, Share, Trends, and Forecast to 2026

Infectious Disease Diagnostics Market - Size, Share, Trends, and Forecast to 2026

Management of infectious diseases can be done with speedy diagnosis, implementation of preventive, and treatment strategies, and strict adherence to the treatment plan. Infectious diseases are lethal and may lead to death if not managed properly and in time. However, rapid and early diagnosis is the key in efficient management of the infectious diseases. Late diagnosis of the diseases often makes it difficult for proper management of the disease and to keep it from spreading.
As the prevalence of infectious diseases is increasing, the need of effective diagnostic tests is also increasing. Centralized laboratory testing has been the gold standard for disease diagnosis. However, emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic would be useful due to unavailability of labs, infrastructure, and trained personnel.
Market Dynamics
Technological advancements to facilitate speedy diagnosis and extensive product portfolios of infectious disease diagnostics offered by manufacturer’s supports the growth of infectious disease diagnostics market. Manufacturers are indulged in providing novel diagnostic solutions for identifying infectious diseases.
For instance, Becton Dickinson and Company launched first automated phenotypic test, BD Phoenix CPO detect test, to detect and classify carbapenemase-producing organisms (CPO) in 2017. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market.
Key features of the study:

This report provides in-depth analysis of infectious disease diagnostics market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global infectious disease diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Becton, Dickinson, and Company, F. Hoffmann La-Roche Ltd., Trinity Biotech Plc, Cardinal Health, Inc., BioMérieux, Bio-Rad Laboratories, Inc., AccuBioTech Co., Ltd., and Acon Laboratories, Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the infectious disease diagnostics market

Detailed Segmentation:

Global Infectious Disease Diagnostics Market, By Product Type:

Kits & Reagents
Instruments

Global Infectious Disease Diagnostics Market, By Disease Type:

HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others

Global Infectious Disease Diagnostics Market, By Technology:

Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others

Global Infectious Disease Diagnostics Market, By Test Location:

Laboratory Testing
Point-of-Care Testing

Global Infectious Disease Diagnostics Market, By End User:

Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others

Global Infectious Disease Diagnostics Market, By Geography:

North America

By Product:

Kits & Reagents
Instruments

By Disease Type:

HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others

By Technology:

Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others

By Test Location

Laboratory Testing
Point-of-Care Testing

By End User:

Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others

By Country:

U.S.
Canada

Europe

By Product:

Kits & Reagents
Instruments

By Disease Type:

HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others

By Technology:

Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others

By Test Location

Laboratory Testing
Point-of-Care Testing

By End User:

Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

By Product:

Kits & Reagents
Instruments

By Disease Type:

HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others

By Technology:

Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others

By Test Location

Laboratory Testing
Point-of-Care Testing

By End User:

Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

By Product:

Kits & Reagents
Instruments

By Disease Type:

HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others

By Technology:

Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others

By Test Location

Laboratory Testing
Point-of-Care Testing

By End User:

Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others

By Country:

Brazil
Mexico
Rest of Latin America

Middle East

By Product:

Kits & Reagents
Instruments

By Disease Type:

HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others

By Technology:

Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others

By Test Location

Laboratory Testing
Point-of-Care Testing

By End User:

Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others

By Country:

GCC
Israel
Rest of Middle East

Africa

By Product:

Kits & Reagents
Instruments

By Disease Type:

HIV
Hepatitis
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Influenza
Others

By Technology:

Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others

By Test Location

Laboratory Testing
Point-of-Care Testing

By End User:

Hospitals
Pathology/Diagnostic Laboratories
Research Institutes
Home-Care Settings
Others

By Country:

Central Africa
South Africa
North Africa

Company Profiles

Danaher Corporation*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Abbott Laboratories
Becton, Dickinson, and Company
Hoffmann La-Roche Ltd.
Trinity Biotech Plc
Cardinal Health, Inc.
BioMérieux
Bio-Rad Laboratories, Inc.
AccuBioTech Co., Ltd.
Acon Laboratories, Inc.

“*” marked represents similar segmentation in other categories in the respective section.


Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Disease Type
Market Snippet, By Technology
Market Snippet, By Test Location
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
PEST Analysis
PORTER’s Analysis
Regulatory Scenario
Global Infectious Disease Diagnostics Market, By Product Type, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Kits & Reagents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Instruments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Global Infectious Disease Diagnostics Market, By Disease Type, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2016 – 2026
Segment Trends
HIV
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Hepatitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Healthcare Associated Infections (HAIs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Human Papillomavirus (HPV)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Tuberculosis (TB)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Influenza
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Global Infectious Disease Diagnostics Market, By Technology, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2016 – 2026
Segment Trends
Immunodiagnostics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Polymerase Chain Reaction (PCR)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Next Generation Sequencing (NGS)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Global Infectious Disease Diagnostics Market, By Test Location, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2016 – 2026
Segment Trends
Laboratory Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Point of Care Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Global Infectious Disease Diagnostics Market, By End User, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2016 – 2026
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Pathology/Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Home-Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Global Infectious Disease Diagnostics Market, By Region, 2016 – 2026 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC
Latin America
Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Technology, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Test Location, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
GCC
Israel
Rest of Middle East
Competitive Landscape
Company Profiles
Danaher Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott Laboratories
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Becton, Dickinson, and Company
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
F.Hoffmann La-Roche Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Trinity Biotech Plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Cardinal Health, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
BioMérieux
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Bio-Rad Laboratories, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
AccuBioTech Co., Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Acon Laboratories, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Section
References
Research Methodology
About us and Sales Contact
*Browse 44 market data tables and 50figures on \Infectious Disease Diagnostics Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report